The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gemcitabine and cisplatin (GP) induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT) versus CCRT alone in locoregionally advanced nasopharyngeal carcinoma (NPC): A phase 3, multicenter, randomized controlled trial.
 
Jun Ma
No Relationships to Disclose
 
Yuan Zhang
No Relationships to Disclose
 
Ying Sun
No Relationships to Disclose
 
Fangyun Xie
No Relationships to Disclose
 
Weihan Hu
No Relationships to Disclose
 
Guoqing Hu
No Relationships to Disclose
 
Ning Zhang
No Relationships to Disclose
 
Kun-Yu Yang
No Relationships to Disclose
 
Xiaodong Zhu
No Relationships to Disclose
 
Feng Jin
No Relationships to Disclose
 
Zhi-Bin Cheng
No Relationships to Disclose
 
Mei Shi
No Relationships to Disclose
 
Fei Han
No Relationships to Disclose
 
Ye Tian
No Relationships to Disclose
 
Yan Sun
No Relationships to Disclose
 
Hao-Yuan Mo
No Relationships to Disclose
 
Jin-Gao Li
No Relationships to Disclose